Betolvex dispensing forms :
Betolvex injection: 1 ml (one ampoule) contains cyanocobalamin/tannin complex equivalent to 1 mg cyanocobalamin
20 mg aluminium monostearate
sesame oil to make 1 ml.
Betolvex tablets: Each tablet contains 1 mg cyanocobalamin.
Betolvex pharmocology :
Vitamin B is essential for life and deficiency brings about the fatal disease of megaloblastic anaemia and/or neurological symptoms. Moreover, vitamin B acts as a coenzyme in many important enzymatic processes.

Betolvex injection :
It is a vitamin B-tannin complex suspended in a sesame oil-aluminium monostearate gel. Vitamin B is gradually released from the site of injection over a long period, simultaneously replenishing the stores in the liver. It is well established that injections of aqueous solutions of vitamin B bring about a short-lasting rise m the serum level, without providing surplus vitamin B for replenishing body stores. As the treatment of a deficiency disease can only be considered satisfactory when the patient’s physiological condition becomes completely normal, the Dumex research laboratories have developed a vitamin B preparation with prolonged action.
Betolvex indications :
In the prophylaxis and therapy of pernicious anaemia and other conditions with vitamin B deficiency.
Examples of such conditions are:
Total gastrectomy. which is always accompanied by hypovitaminosis.
Vitamin B hypovitaminosis with macrocytic anaemia and/or neuropathy.
– after gastric resection
– after ileocoecal resection and proctocolectomy
– in sprue and symptomatic steatorrhoea
– in sure after intestinal shunt for adipositas
– with inadequate nutrition. where the cause is malnutrition or unsuitable diet, particularly in the case of elderly people who often suffer from atrophic gastritis, and vegetarians whose diet is entirely lacking in animal protein.
Betolvex Contraindications :
Known allergy to vitamin B. Leber’s optic atrophy, inherited optic atrophy, tobacco-alcohol amblyopia tropical atoxic neuropathy
Betolvex precautions :
none
Betolvex during pregnancy and lactation :
In the recommended dosage. Betolvex is not harmful to the fetus or breastfed child.
Betolvex side effects :
None.
Betolvex overdosage :
There is no risk of overdosage and intoxication with Belolvex”‘.
Betolvex interactions :
None.
Betolvex dosage :
In conditions where stores are presumed to be depleted (pernicious anaemia, gastrectomy): One – intramuscular injection of 1 ml of Betolvex every week for 4 weeks. Thereafter 1 ml of Betolvex every 3 months.
Otherwise: 1 ml of Betolvex every 3 months.
Produced by :
MINAPHARM Under Licence of
AlPHARMA Denmark